Literature DB >> 25432779

Comment on: "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance".

Rave Harpaz1, William DuMouchel, Nigam H Shah.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25432779      PMCID： PMC4706737          DOI： 10.1007/s40264-014-0245-9

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  7 in total

1.  Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.

Authors:  G Niklas Norén; Ola Caster; Kristina Juhlin; Marie Lindquist
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

Review 2.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

3.  Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.

Authors:  R Harpaz; W DuMouchel; P LePendu; A Bauer-Mehren; P Ryan; N H Shah
Journal:  Clin Pharmacol Ther       Date:  2013-02-11       Impact factor: 6.875

4.  Pharmacovigilance using clinical notes.

Authors:  P LePendu; S V Iyer; A Bauer-Mehren; R Harpaz; J M Mortensen; T Podchiyska; T A Ferris; N H Shah
Journal:  Clin Pharmacol Ther       Date:  2013-03-04       Impact factor: 6.875

5.  A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.

Authors:  Preciosa M Coloma; Paul Avillach; Francesco Salvo; Martijn J Schuemie; Carmen Ferrajolo; Antoine Pariente; Annie Fourrier-Réglat; Mariam Molokhia; Vaishali Patadia; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

6.  Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.

Authors:  Richard D Boyce; Patrick B Ryan; G Niklas Norén; Martijn J Schuemie; Christian Reich; Jon Duke; Nicholas P Tatonetti; Gianluca Trifirò; Rave Harpaz; J Marc Overhage; Abraham G Hartzema; Mark Khayter; Erica A Voss; Christophe G Lambert; Vojtech Huser; Michel Dumontier
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

7.  A time-indexed reference standard of adverse drug reactions.

Authors:  Rave Harpaz; David Odgers; Greg Gaskin; William DuMouchel; Rainer Winnenburg; Olivier Bodenreider; Anna Ripple; Ana Szarfman; Alfred Sorbello; Eric Horvitz; Ryen W White; Nigam H Shah
Journal:  Sci Data       Date:  2014-11-11       Impact factor: 6.444
  7 in total
  5 in total

1.  A method for systematic discovery of adverse drug events from clinical notes.

Authors:  Guan Wang; Kenneth Jung; Rainer Winnenburg; Nigam H Shah
Journal:  J Am Med Inform Assoc       Date:  2015-07-31       Impact factor: 4.497

2.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

3.  Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.

Authors:  Justin Mower; Devika Subramanian; Trevor Cohen
Journal:  J Am Med Inform Assoc       Date:  2018-10-01       Impact factor: 4.497

4.  A reference set of clinically relevant adverse drug-drug interactions.

Authors:  Elpida Kontsioti; Simon Maskell; Bhaskar Dutta; Munir Pirmohamed
Journal:  Sci Data       Date:  2022-03-04       Impact factor: 6.444

5.  Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature.

Authors:  Rainer Winnenburg; Nigam H Shah
Journal:  BMC Bioinformatics       Date:  2016-06-23       Impact factor: 3.169
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.